engleski

The case against premature treatment of heart failure patients with implantable cardioverter-defibrillators: results from an institutional registry

mplantable cardioverter-defibrillators (ICD) are gold-standard therapy for primary prevention (PP) of sudden cardiac death (SCD) in patients with heart failure with reduced ejection fraction (HFrEF). According to relevant guidelines, ICDs should be implanted only after patients have been treated with revascularization procedures and/or optimal medical therapy (OMT) [1]. Due to perceived high risk of SCD and low chance of improvement some patients receive ICDs “too early” in the course of the disease [2].Aim of the study was to investigate adherence to guidelines in our institution with emphasis on premature ICD implantation and early ICD activation. We analysed all ICDs newly implanted for PP in patients with HFrEF in our institution between 2011 and 2017. Follow-up data was collected from hospital medical records

ICD, heart failure, Sudden cardiac death

nije evidentirano